Sinusitis decisions — 2025

The Board denied service connection for bilateral hearing loss and sinusitis, granted service connection for tinnitus, and remanded claims related to the right ankle, low back, and residuals of a right triquetral fracture.

The Board granted service connection for tinnitus and increased the rating for major depressive disorder to 50 percent, while denying increased ratings for allergic rhinitis, bilateral hearing loss, chronic sinusitis, and external hemorrhoids.

The Veteran's service connection for colorectal polyps was granted, while the claims for right ear hearing loss and other conditions were denied or partially granted. The PTSD with alcohol use disorder with TBI received a 70 percent rating.

The Board remands the claims for a retrospective opinion to determine the severity of the Veteran's service-connected rhinitis and sinusitis during the current appellate period.

The Board granted service connection for chronic bronchitis, a presumptive disability linked to burn pits and other toxins (BPOT) under the provisions of the PACT Act. The claims for service connection for a sinus / sinusitis disorder separate from non-allergic rhinitis and deviated nasal septum, and an increased rating for non-allergic rhinitis and deviated nasal septum were denied.

The Board denied the veteran's claims for an initial compensable disability rating for sinusitis and rhinitis, as well as service connection for a left ankle strain.

The Board denied service connection for multiple conditions, including ankle pain, chronic lower back pain, GERD, hair thinning/loss, IBS, and others, as there was no evidence of a current diagnosis.

The Board denied an earlier effective date for TBI, a compensable rating for TBI, and granted service connection for GERD as secondary to the Veteran's service-connected disabilities.

The Board granted an initial 60 percent rating for coronary artery disease (CAD), status post myocardial infarction, and a total disability rating based on individual unemployability (TDIU) effective May 27, 2021.

The Board granted service connection for right and left knee, cervical spine, lumbar spine, and sciatic radiculopathy disabilities but denied increased ratings for the psychiatric disorder and other conditions.

The Board granted an earlier effective date of November 29, 2021 for a 20 percent rating for the right foot status post calcaneal fracture and a noncompensable (0 percent) rating for the right foot scar. The appeal was denied for other issues.

The Veteran withdrew the appeals for service connection for chronic fatigue syndrome and chronic sinusitis.

The Board granted an initial 30 percent evaluation for allergic rhinitis based on the presence of nasal polyps.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support higher ratings or service connection for any of the conditions appealed.

The Board granted service connection for lumbosacral strain and allergic rhinitis, assigned a 10 percent rating for allergic rhinitis, and denied service connection for the other conditions.

The Board denied service connection for rhinitis, sinusitis, and irritable bowel syndrome (IBS) as there is no evidence of a current diagnosis or etiology related to the Veteran's service.

The Board remands the claims for service connection for residuals of prostate cancer, arthrosclerosis (claimed as a heart condition), allergic rhinitis, depressive disorder, and complex partial seizures evolving to generalized seizure due to incomplete service treatment records and the need for additional evidence regarding in-service herbicide exposure.

The Board denied an initial compensable rating for chronic rhinitis but granted a 10 percent disability rating for chronic sinusitis.

The Board denied an initial disability rating in excess of 10 percent for allergic rhinitis prior to April 13, 2023, and a disability rating in excess of 30 percent from that date.

The Board granted a rating of 30 percent for pseudofolliculitis barbae and an initial rating of 10 percent prior to August 21, 2021, and a 30 percent rating thereafter for sinusitis.